Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Novel methods for the preparation and characterization of hyaluronan oligosaccharides of defined length.

Identifieur interne : 003431 ( Main/Exploration ); précédent : 003430; suivant : 003432

Novel methods for the preparation and characterization of hyaluronan oligosaccharides of defined length.

Auteurs : D J Mahoney [Royaume-Uni] ; R T Aplin ; A. Calabro ; V C Hascall ; A J Day

Source :

RBID : pubmed:11805075

Descripteurs français

English descriptors

Abstract

Hyaluronan is a ubiquitous glycosaminoglycan of high molecular weight that acts as a structural component of extracellular matrices and mediates cell adhesion. There have been numerous recent reports that fragments of hyaluronan have different properties compared to the intact molecule. Though many of these results may be genuine, it is possible that some activities are due to minor components in the preparations used. Therefore, it is important that well-characterized and highly purified oligosaccharides are used in cell biological and structural studies so that erroneous results are avoided. We present methods for the purification of hyaluronan oligomers of defined size using size exclusion and anion-exchange chromatography following digestion of hyaluronan with testicular hyaluronidase. These preparations were characterized by a combination of electrospray ionization mass spectrometry, matrix-assisted laser desorption/ionization mass spectrometry with time-of-flight analysis, and fluorophore-assisted carbohydrate electrophoresis. Hyaluronan oligomers ranging from tetrasaccharides to 34-mers were separated. The 4- to 16-mers were shown to be homogeneous with regard to length but did contain varying amounts of chondroitin sulfate. This contaminant could have been minimized if digestion had been performed with medical-grade hyaluronan rather than the relatively impure starting material used here. The 18- to 34-mer preparations were mixtures of oligosaccharides of different lengths (e.g., the latter contained 87% 34-mer, 10% 32-mer, and 3% 30-mer) but were free of detectable chondroitin sulfate. In addition to oligomers with even numbers of sugar rings, novel 5- and 7-mers with terminal glucuronic acid residues were identified.

DOI: 10.1093/glycob/11.12.1025
PubMed: 11805075


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Novel methods for the preparation and characterization of hyaluronan oligosaccharides of defined length.</title>
<author>
<name sortKey="Mahoney, D J" sort="Mahoney, D J" uniqKey="Mahoney D" first="D J" last="Mahoney">D J Mahoney</name>
<affiliation wicri:level="4">
<nlm:affiliation>MRC Immunochemistry Unit, Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>MRC Immunochemistry Unit, Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU</wicri:regionArea>
<orgName type="university">Université d'Oxford</orgName>
<placeName>
<settlement type="city">Oxford</settlement>
<region type="nation">Angleterre</region>
<region type="région" nuts="1">Oxfordshire</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Aplin, R T" sort="Aplin, R T" uniqKey="Aplin R" first="R T" last="Aplin">R T Aplin</name>
</author>
<author>
<name sortKey="Calabro, A" sort="Calabro, A" uniqKey="Calabro A" first="A" last="Calabro">A. Calabro</name>
</author>
<author>
<name sortKey="Hascall, V C" sort="Hascall, V C" uniqKey="Hascall V" first="V C" last="Hascall">V C Hascall</name>
</author>
<author>
<name sortKey="Day, A J" sort="Day, A J" uniqKey="Day A" first="A J" last="Day">A J Day</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2001">2001</date>
<idno type="RBID">pubmed:11805075</idno>
<idno type="pmid">11805075</idno>
<idno type="doi">10.1093/glycob/11.12.1025</idno>
<idno type="wicri:Area/PubMed/Corpus">002524</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002524</idno>
<idno type="wicri:Area/PubMed/Curation">002524</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002524</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002403</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002403</idno>
<idno type="wicri:Area/Ncbi/Merge">000122</idno>
<idno type="wicri:Area/Ncbi/Curation">000122</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000122</idno>
<idno type="wicri:doubleKey">0959-6658:2001:Mahoney D:novel:methods:for</idno>
<idno type="wicri:Area/Main/Merge">003467</idno>
<idno type="wicri:Area/Main/Curation">003431</idno>
<idno type="wicri:Area/Main/Exploration">003431</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Novel methods for the preparation and characterization of hyaluronan oligosaccharides of defined length.</title>
<author>
<name sortKey="Mahoney, D J" sort="Mahoney, D J" uniqKey="Mahoney D" first="D J" last="Mahoney">D J Mahoney</name>
<affiliation wicri:level="4">
<nlm:affiliation>MRC Immunochemistry Unit, Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>MRC Immunochemistry Unit, Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU</wicri:regionArea>
<orgName type="university">Université d'Oxford</orgName>
<placeName>
<settlement type="city">Oxford</settlement>
<region type="nation">Angleterre</region>
<region type="région" nuts="1">Oxfordshire</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Aplin, R T" sort="Aplin, R T" uniqKey="Aplin R" first="R T" last="Aplin">R T Aplin</name>
</author>
<author>
<name sortKey="Calabro, A" sort="Calabro, A" uniqKey="Calabro A" first="A" last="Calabro">A. Calabro</name>
</author>
<author>
<name sortKey="Hascall, V C" sort="Hascall, V C" uniqKey="Hascall V" first="V C" last="Hascall">V C Hascall</name>
</author>
<author>
<name sortKey="Day, A J" sort="Day, A J" uniqKey="Day A" first="A J" last="Day">A J Day</name>
</author>
</analytic>
<series>
<title level="j">Glycobiology</title>
<idno type="ISSN">0959-6658</idno>
<imprint>
<date when="2001" type="published">2001</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Carbohydrate Sequence</term>
<term>Chondroitin Sulfates (chemistry)</term>
<term>Chromatography, Gel (methods)</term>
<term>Chromatography, High Pressure Liquid (methods)</term>
<term>Chromatography, Ion Exchange (methods)</term>
<term>Electrophoresis (methods)</term>
<term>Fluorescent Dyes (chemistry)</term>
<term>Humans</term>
<term>Hyaluronic Acid (chemistry)</term>
<term>Hyaluronic Acid (isolation & purification)</term>
<term>Hyaluronoglucosaminidase (metabolism)</term>
<term>Infant, Newborn</term>
<term>Male</term>
<term>Molecular Weight</term>
<term>Oligosaccharides (analysis)</term>
<term>Oligosaccharides (isolation & purification)</term>
<term>Sheep</term>
<term>Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization (methods)</term>
<term>Umbilical Cord (chemistry)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Acide hyaluronique ()</term>
<term>Acide hyaluronique (isolement et purification)</term>
<term>Animaux</term>
<term>Chondroïtines sulfate ()</term>
<term>Chromatographie d'échange d'ions ()</term>
<term>Chromatographie en phase liquide à haute performance ()</term>
<term>Chromatographie sur gel ()</term>
<term>Colorants fluorescents ()</term>
<term>Cordon ombilical ()</term>
<term>Humains</term>
<term>Hyaluronoglucosaminidase (métabolisme)</term>
<term>Masse moléculaire</term>
<term>Mâle</term>
<term>Nouveau-né</term>
<term>Oligosaccharides (analyse)</term>
<term>Oligosaccharides (isolement et purification)</term>
<term>Ovis</term>
<term>Spectrométrie de masse MALDI ()</term>
<term>Séquence glucidique</term>
<term>Électrophorèse ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en">
<term>Oligosaccharides</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Chondroitin Sulfates</term>
<term>Fluorescent Dyes</term>
<term>Hyaluronic Acid</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="isolation & purification" xml:lang="en">
<term>Hyaluronic Acid</term>
<term>Oligosaccharides</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Hyaluronoglucosaminidase</term>
</keywords>
<keywords scheme="MESH" qualifier="analyse" xml:lang="fr">
<term>Oligosaccharides</term>
</keywords>
<keywords scheme="MESH" qualifier="chemistry" xml:lang="en">
<term>Umbilical Cord</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr">
<term>Acide hyaluronique</term>
<term>Oligosaccharides</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Chromatography, Gel</term>
<term>Chromatography, High Pressure Liquid</term>
<term>Chromatography, Ion Exchange</term>
<term>Electrophoresis</term>
<term>Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Hyaluronoglucosaminidase</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Carbohydrate Sequence</term>
<term>Humans</term>
<term>Infant, Newborn</term>
<term>Male</term>
<term>Molecular Weight</term>
<term>Sheep</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Acide hyaluronique</term>
<term>Animaux</term>
<term>Chondroïtines sulfate</term>
<term>Chromatographie d'échange d'ions</term>
<term>Chromatographie en phase liquide à haute performance</term>
<term>Chromatographie sur gel</term>
<term>Colorants fluorescents</term>
<term>Cordon ombilical</term>
<term>Humains</term>
<term>Masse moléculaire</term>
<term>Mâle</term>
<term>Nouveau-né</term>
<term>Ovis</term>
<term>Spectrométrie de masse MALDI</term>
<term>Séquence glucidique</term>
<term>Électrophorèse</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Hyaluronan is a ubiquitous glycosaminoglycan of high molecular weight that acts as a structural component of extracellular matrices and mediates cell adhesion. There have been numerous recent reports that fragments of hyaluronan have different properties compared to the intact molecule. Though many of these results may be genuine, it is possible that some activities are due to minor components in the preparations used. Therefore, it is important that well-characterized and highly purified oligosaccharides are used in cell biological and structural studies so that erroneous results are avoided. We present methods for the purification of hyaluronan oligomers of defined size using size exclusion and anion-exchange chromatography following digestion of hyaluronan with testicular hyaluronidase. These preparations were characterized by a combination of electrospray ionization mass spectrometry, matrix-assisted laser desorption/ionization mass spectrometry with time-of-flight analysis, and fluorophore-assisted carbohydrate electrophoresis. Hyaluronan oligomers ranging from tetrasaccharides to 34-mers were separated. The 4- to 16-mers were shown to be homogeneous with regard to length but did contain varying amounts of chondroitin sulfate. This contaminant could have been minimized if digestion had been performed with medical-grade hyaluronan rather than the relatively impure starting material used here. The 18- to 34-mer preparations were mixtures of oligosaccharides of different lengths (e.g., the latter contained 87% 34-mer, 10% 32-mer, and 3% 30-mer) but were free of detectable chondroitin sulfate. In addition to oligomers with even numbers of sugar rings, novel 5- and 7-mers with terminal glucuronic acid residues were identified.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Royaume-Uni</li>
</country>
<region>
<li>Angleterre</li>
<li>Oxfordshire</li>
</region>
<settlement>
<li>Oxford</li>
</settlement>
<orgName>
<li>Université d'Oxford</li>
</orgName>
</list>
<tree>
<noCountry>
<name sortKey="Aplin, R T" sort="Aplin, R T" uniqKey="Aplin R" first="R T" last="Aplin">R T Aplin</name>
<name sortKey="Calabro, A" sort="Calabro, A" uniqKey="Calabro A" first="A" last="Calabro">A. Calabro</name>
<name sortKey="Day, A J" sort="Day, A J" uniqKey="Day A" first="A J" last="Day">A J Day</name>
<name sortKey="Hascall, V C" sort="Hascall, V C" uniqKey="Hascall V" first="V C" last="Hascall">V C Hascall</name>
</noCountry>
<country name="Royaume-Uni">
<region name="Angleterre">
<name sortKey="Mahoney, D J" sort="Mahoney, D J" uniqKey="Mahoney D" first="D J" last="Mahoney">D J Mahoney</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003431 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003431 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:11805075
   |texte=   Novel methods for the preparation and characterization of hyaluronan oligosaccharides of defined length.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:11805075" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021